An aqueous Ophthalmic Solution comprising an immunosuppressive Agent, preferably a Cyclosporin a Derivative of Cellulose, as a First Polymer, a Second Polymer such as polyvinyl Derivative, a polymer with a lipophilic Functional Group as a Third Polymer, its Preparation Process and use L to treat disorders of the eye surface immunological or inflammatory basis.
